Mologen AG Product Size & Share - 2015

1
Mologen AG Product Pipeline Review - 2015
Published on October - 2015
2
.
Report Overview
About Mologen AG Product Pipeline Review
2015 Global Markets Directs, Mologen AG Product
Pipeline Review - 2015, provides an overview of
the Mologen AGs pharmaceutical research and
development focus. This report provides
comprehensive information on the current
therapeutic developmental pipeline of Mologen
AGs, complete with comparative analysis at
various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects. Global
Markets Directs report features investigational
drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is
built using data and information sourced from
Global Markets Directs proprietary data bases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/molo
gen-ag-product-pipeline-review-2015-market

3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of Mologen AG including business
description, key information and facts, and its
locations and subsidiaries The report reviews
current pipeline of Mologen AG s human
therapeutic division and enlists all their major
and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
Mologen AG spipeline products   Reasons to
buy Evaluate Mologen AG sstrategic position with
total access to detailed information on its
product pipeline Assess the growth potential of
Mologen AG in its therapy areas of focus Identify
new drug targets and therapeutic classes in the
Mologen AG s RD portfolio and develop key
strategic initiatives to reinforce pipeline in
those areas Exploit in-licensing opportunities by
identifying windows of opportunity to fill
portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of Mologen AG and exploit
  collaboration and partnership opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of
  Mologen AG
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  Mologen AG and identify potential opportunities
  in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4List of Figures 4Mologen AG
Snapshot 5Mologen AG Overview 5Key Information
5Key Facts 5Mologen AG - Research and
Development Overview 6Key Therapeutic Areas
6Mologen AG - Pipeline Review 8Pipeline
Products by Stage of Development 8Pipeline
Products - Monotherapy 9Mologen AG - Pipeline
Products Glance 10Mologen AG - Late Stage
Pipeline Products 10Phase III Products/Combinatio
n Treatment Modalities 10
7
Table Of Contents
Mologen AG - Clinical Stage Pipeline Products
11Phase II Products/Combination Treatment
Modalities 11Phase I Products/Combination
Treatment Modalities 12 Mologen AG - Early Stage
Pipeline Products 13Preclinical
Products/Combination Treatment Modalities
13Mologen AG - Drug Profiles 14MGN-1703
14Product Description 14Mechanism of Action
14RD Progress 14MGN-1601 18Product
Description 18Mechanism of Action 18RD
Progress 18
8
Table Of Contents
MGN-1404 20 Product Description 20Mechanism of
Action 20RD Progress 20MGN-1331 21Product
Description 21Mechanism of Action 21RD
Progress 21MGN-1333 22  Enquiry about this
report _at_ http//www.researchbeam.com/mologen-ag-pr
oduct-pipeline-review-2015-market/enquire-about-re
port
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/mologen-ag-product-pip
eline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com